Status:

RECRUITING

Evaluate the Continued Safety and Performance of the Foot and Ankle Products

Lead Sponsor:

Arthrex, Inc.

Conditions:

Hyperpronated Foot

Reconstruction Surgeries of the Foot

Eligibility:

All Genders

2+ years

Brief Summary

The objective of the registry is to evaluate the continued safety and performance of Arthrex foot and ankle products, including the ProStop® implant for hyperpronated foot; Bio-Compression Screw for r...

Detailed Description

Device-related adverse events will be continuously assessed and summarized at three months, six months, one year, and two years postoperatively to evaluate safety. A physical exam of the target area w...

Eligibility Criteria

Inclusion

  • Subject requires surgery using Arthrex foot and ankle products included in the registry.
  • Subject is 18 years of age or over (all products except ProStop®).
  • Subject age \>two to 17 years (ProStop® product only).
  • Capable of completing self-administered questionnaires.
  • Willing and able to return for all study-related follow-up visits.
  • Subject or subject's representative signed informed consent and assent, when applicable, and is willing and able to comply with all study requirements.
  • (ArthroFLEX® subjects only):
  • Degenerative or post-traumatic arthritis of the 1st MTP joint with grade 2, 3, or 4.
  • Subjects who require surgical intervention or are medically indicated for an arthrodesis or arthroplasty of the 1st MTP.
  • DualCompression Hindfoot Nail subjects only:
  • The participant must have instability, arthritis, rigid deformity, or severe foot or ankle deformity necessitating tibiotalocalcaneal arthrodesis, commonly referred to as TTC arthrodesis.
  • The participant should be undergoing treatment with the Arthrex DualCompression Hindfoot Nail, either as a primary procedure or as a revision surgery, per standard of care

Exclusion

  • Insufficient quantity or quality of bone.
  • Blood supply limitations and previous infections, which may retard healing.
  • Foreign-body sensitivity.
  • Any active infection or blood supply limitations.
  • Conditions that tend to limit the patient's ability or willingness to restrict activities or follow directions during the healing period.
  • Subjects that are skeletally immature (except for ProStop®).
  • Subject is considered from vulnerable population (i.e., child, prisoner, pregnant).
  • Subjects who are contraindicated for these devices.
  • Subject is currently receiving compensation or benefits due to a work-related injury or illness under any applicable occupational injury or disability program.
  • Subject has a planned or scheduled additional surgery on the affected or contralateral lower extremity within the course of the study.
  • (® Nitinol Staple Subjects only):
  • Subjects who have a comminuted bone surface that would not allow for staple placement as required by the DynaNite® Nitinol Staples directions for use.
  • Subjects who have pathologic bone conditions such as osteopenia that would impair the ability to securely fix the implant as required by the DynaNite® Nitinol Staples directions for use.
  • (ArthroFLEX® subjects only):
  • Additional ipsilateral lower limb pathology that requires active treatment.
  • Bilateral degenerative or post-traumatic arthritis of the 1st MTP joints that would require simultaneous treatment of both MTP joints.
  • Diagnosis of gout.
  • Any significant bone loss, avascular necrosis, and/or large osteochondral cyst (\>1cm) of the 1st MTP joint.
  • Lesions greater than 10mm in size.
  • Hallux varus to any degree, or hallux valgus \>20 degrees.
  • (DualCompression Hindfoot Nail subjects only):
  • Requiring only a tibiotalar or subtalar arthrodesis
  • Patient requires bulk allograft or metal spacer implant to fill large bony defect and aid in limb salvage

Key Trial Info

Start Date :

December 1 2020

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 31 2027

Estimated Enrollment :

700 Patients enrolled

Trial Details

Trial ID

NCT04715139

Start Date

December 1 2020

End Date

December 31 2027

Last Update

June 26 2025

Active Locations (6)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (6 locations)

1

UC Davis Medical Center

Sacramento, California, United States, 95817

2

TOA Research Foundation

Nashville, Tennessee, United States, 37209

3

Barrett Podiatry

San Antonio, Texas, United States, 78258

4

Atlantic Orthopaedic Specialists

Virginia Beach, Virginia, United States, 23462